Revvity Inc at Goldman Sachs Healthcare Conference Transcript
Great. Thanks, everyone, for joining this morning. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Max Krakowiak, the CFO of Revvity. Thank you very much, Max, for being here.
Absolutely.
Questions & Answers
Maybe it would be great for you to start out kind of set the stage first to talk about the most recent results, trends you're seeing in your business. And also, there was a slight name change and everything. Maybe talk a little bit about that.
Yes, sure. So I think if we go back to the commentary we had on the first quarter call. Q1 came in, I would say, probably at the upper end of our expectations.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
